arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

STAAR Surgical Company

STAA Health Care Ophthalmic Goods
$23.47
Today
as of Sep 4, 16:54 ET
Last 30 days +2.27% Jul 27 → Sep 04
$21.78 $22.96 $24.15 $25.33 $26.51 Jul 27 Aug 04 Aug 12 Aug 19 Aug 27 Sep 04
Open
$23.47
High
$24.36
Low
$23.40
Volume
$2M
Avg Vol
$1M
Mkt Cap
$1.3B
P/E (TTM)
50.25
Beta
—
52w High
$35.87
52w Low
$15.59
Div Yield
—
Shares Out
$50M

Recent Press Releases & News last 60 days · 25 items

Sep 2 · 20:57 MT Newswires
STAAR Surgical Appoints Ben Park as Chief Technology Officer
Sep 2 · 20:01 PR Business Wire
STAAR Surgical Names Medtech Innovator and Platform Builder Ben Park as Chief Technology Officer
Aug 20 · 00:13 Motley Fool
STAAR (STAA) Q2 2026 Earnings Call Transcript
▸ Show all 25 press releases & news Free account →

Overview

52-week range
$16
$36
39% of range
Avg surprise (last 3)
+378.5%
Avg reaction (last 2)
+4.3%
100% positive
Latest IV / EM
76%
EM ±11.8% · $23 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.67$-0.43$-0.19$0.05$0.29 Actual $0.05Actual $0.12Actual $0.10Actual $-0.07Actual $0.15Actual $0.20Actual $-0.64Est $-0.66Actual $-0.23Est $-0.67Actual $0.18Actual $0.29Est $-0.03Actual $0.16 MarJunSepMarJunSepMar/2025Jun/2025SepMar/2026Jul
Revenue vs Net Income Revenue Net income
$-54M$-16M$23M$61M$99M Sep 24Mar 25Jun 25Sep 25Apr 26Jul 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Fri Jul 3, 2026Jul 2026 $0.16 — — — — financials
Wed May 13, 2026Mar/2026 $0.29 $-0.03 +1,067% +145.3% +4.3% earnings
Fri Sep 26, 2025Sep 2025 $0.18 — — — — financials
Wed Aug 6, 2025Jun/2025 $-0.23 $-0.67 +65.7% — — earnings
Wed May 7, 2025Mar/2025 $-0.64 $-0.66 +3.0% — +4.3% earnings
Fri Sep 27, 2024Sep 2024 $0.20 — — — — financials
Fri Jun 28, 2024Jun 2024 $0.15 — — — — financials
Fri Mar 29, 2024Mar 2024 $-0.07 — — — — financials
Fri Sep 29, 2023Sep 2023 $0.10 — — — — financials
Fri Jun 30, 2023Jun 2023 $0.12 — — — — financials
Fri Mar 31, 2023Mar 2023 $0.05 — — — — financials

Financials

Income statement (quarterly)

MetricJul 2026Apr 2026Jan 2026Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$94M$94M—$95M$44M$43M—$89M
Cost of revenue$24M$25M—$17M$12M$15M—$20M
Gross profit$70M$69M—$78M$33M$28M—$68M
Operating income$10M$8M—$18M$-30M$-57M—$6M
Net income$8M$5M—$9M$-17M$-54M—$10M
EPS (diluted)$0.16$0.10—$0.18$-0.34$-1.10—$0.20

Balance sheet (quarterly)

MetricJul 2026Apr 2026Jan 2026Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$149M$132M$153M$176M$167M$173M$144M$164M
Inventory————————
Total current assets$342M$312M$312M$321M$293M$326M$368M$397M
Total assets$475M$451M$452M$456M$438M$457M$510M$538M
Long-term debt————————
Total liabilities$110M$99M$107M$103M$101M$107M$112M$109M
Total equity$365M$352M$344M$354M$337M$350M$397M$428M

Implied volatility — last 90 days

31%231%431%631%831% Jun 07 — IV 83% · EM ±11.5%Jun 08 — IV 56% · EM ±7.4%Jun 09 — IV 57% · EM ±7.2%Jun 10 — IV 61% · EM ±7.2%Jun 11 — IV 84% · EM ±9.3%Jun 12 — IV 121% · EM ±12.3%Jun 15 — IV 197% · EM ±14.3%Jun 16 — IV 155% · EM ±9.2%Jun 17 — IV 234% · EM ±9.8%Jun 19 — IV 50% · EM ±11.2%Jun 22 — IV 55% · EM ±11.5%Jun 23 — IV 51% · EM ±10.5%Jun 24 — IV 78% · EM ±15.6%Jun 25 — IV 71% · EM ±13.9%Jun 26 — IV 50% · EM ±9.6%Jun 29 — IV 51% · EM ±9.1%Jun 30 — IV 55% · EM ±9.5%Jul 01 — IV 94% · EM ±15.6%Jul 02 — IV 60% · EM ±9.6%Jul 03 — IV 62% · EM ±9.6%Jul 06 — IV 76% · EM ±10.5%Jul 07 — IV 80% · EM ±10.5%Jul 08 — IV 70% · EM ±8.8%Jul 09 — IV 68% · EM ±8.0%Jul 10 — IV 47% · EM ±5.2%Jul 13 — IV 43% · EM ±3.6%Jul 14 — IV 48% · EM ±3.5%Jul 15 — IV 107% · EM ±6.3%Jul 16 — IV 831% · EM ±34.7%Jul 20 — IV 66% · EM ±15.6%Jul 21 — IV 62% · EM ±14.4%Jul 22 — IV 68% · EM ±15.6%Jul 23 — IV 67% · EM ±15.0%Jul 24 — IV 66% · EM ±14.5%Jul 27 — IV 73% · EM ±15.3%Jul 28 — IV 62% · EM ±12.7%Jul 29 — IV 91% · EM ±18.2%Jul 30 — IV 67% · EM ±13.1%Jul 31 — IV 83% · EM ±15.8%Aug 03 — IV 99% · EM ±17.5%Aug 04 — IV 82% · EM ±14.2%Aug 05 — IV 71% · EM ±11.8%Aug 06 — IV 84% · EM ±13.5%Aug 07 — IV 67% · EM ±10.5%Aug 10 — IV 83% · EM ±11.4%Aug 11 — IV 93% · EM ±12.2%Aug 12 — IV 120% · EM ±15.1%Aug 13 — IV 52% · EM ±6.1%Aug 14 — IV 61% · EM ±6.8%Aug 17 — IV 63% · EM ±5.3%Aug 18 — IV 65% · EM ±4.7%Aug 19 — IV 74% · EM ±4.4%Aug 20 — IV 42% · EM ±1.7%Aug 24 — IV 66% · EM ±13.8%Aug 25 — IV 42% · EM ±8.6%Aug 26 — IV 39% · EM ±7.8%Aug 27 — IV 40% · EM ±7.8%Aug 28 — IV 31% · EM ±6.0%Aug 31 — IV 37% · EM ±6.6%Sep 01 — IV 38% · EM ±6.6%Sep 02 — IV 63% · EM ±10.6%Sep 03 — IV 44% · EM ±7.1%Sep 04 — IV 76% · EM ±11.8%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,148.00-0.1%
JNJ
Johnson & Johnson
$671.0B $275.71+0.2%
ABBV
AbbVie Inc.
$430.9B $256.50+0.1%
MRK
Merck & Company, Inc.
$317.1B $150.33+0.0%
PM
Philip Morris International Inc
$299.3B $182.53+0.0%
NVS
Novartis AG
$297.9B $155.11-3.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in